Obligacje
Poniżej znajduje się lista obligacji korporacyjnych AbbVie, Inc.. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
---|---|---|---|---|---|---|---|---|---|
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7,00% | 26 K | 76,04% | 4,750% | 2045-03-15 | 53,51 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6,83% | 12 K | 77,91% | 4,625% | 2042-10-01 | 67,49 M USD | 1 000,00 USD | 2 000,00 USD | Actavis, Inc. |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6,51% | 202 K | 82,12% | 4,850% | 2044-06-15 | 65,23 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
5,72% | 0 | 91,48% | 2,625% | 2028-11-15 | 72,11 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS | |
5,49% | 26 K | 90,47% | 3,200% | 2029-11-21 | 62,52 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,39% | 997 K | 101,73% | 5,500% | 2064-03-15 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,33% | 4,73 M | 103,94% | 5,600% | 2055-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,31% | 0 | 89,32% | 4,450% | 2046-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,30% | 3,62 M | 101,34% | 5,400% | 2054-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,30% | 12,41 M | 85,76% | 4,250% | 2049-11-21 | 5,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5,30% | 22 K | 94,50% | 4,550% | 2035-03-15 | 107,65 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
5,29% | 0 | 92,80% | 4,700% | 2045-05-14 | 2,7 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,28% | 5,4 M | 94,56% | 4,875% | 2048-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,25% | 175 K | 93,89% | 4,750% | 2045-03-15 | 827,09 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,22% | 856 K | 95,57% | 4,850% | 2044-06-15 | 1,01 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,22% | 30 K | 93,36% | 4,625% | 2042-10-01 | 389,22 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,20% | 2,93 M | 101,69% | 5,350% | 2044-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,16% | 1,56 M | 91,44% | 4,400% | 2042-11-06 | 2,6 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,96% | 800 K | 90,81% | 4,050% | 2039-11-21 | 4 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,70% | 0 | 96,71% | 4,300% | 2036-05-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,64% | 0 | 98,88% | 4,500% | 2035-05-14 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,60% | 5,99 M | 104,56% | 5,200% | 2035-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,59% | 23,61 M | 99,72% | 4,550% | 2035-03-15 | 1,68 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,54% | 1,83 M | 103,54% | 5,050% | 2034-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,09% | 6,13 M | 104,15% | 4,950% | 2031-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,04% | 0 | 99,54% | 3,200% | 2026-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,98% | 216 K | 103,60% | 4,875% | 2030-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,96% | 3,65 M | 97,14% | 3,200% | 2029-11-21 | 5,44 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,93% | 6,98 M | 102,75% | 4,800% | 2029-03-15 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,88% | 2,46 M | 101,26% | 4,800% | 2027-03-15 | 2,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 3,86% | 0 | 94,21% | 2,125% | 2029-06-01 | 36,46 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS |
3,82% | 8,57 M | 101,90% | 4,650% | 2028-03-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,81% | 2,84 M | 101,24% | 4,250% | 2028-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,75% | 13,95 M | 99,15% | 2,950% | 2026-11-21 | 3,99 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,16% | 0 | 126,76% | 4,750% | 2045-03-15 | 5 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,13% | 0 | 128,71% | 4,850% | 2044-06-15 | 100 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,13% | 0 | 121,31% | 4,250% | 2049-11-21 | 4,95 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,79% | 0 | 91,49% | 1,250% | 2031-11-18 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,57% | 0 | 123,74% | 4,550% | 2035-03-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,57% | 0 | 98,48% | 2,125% | 2029-06-01 | 506,09 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,48% | 0 | 98,96% | 2,125% | 2028-11-17 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,45% | 0 | 100,52% | 2,625% | 2028-11-15 | 427,79 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,29% | 0 | 96,89% | 0,750% | 2027-11-18 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
−5,92% | 0 | 111,17% | 2,950% | 2026-11-21 | 9,24 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
— | — | — | 4,400% | 2042-11-06 | 1,1 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |